Shandong Oriental Ocean unit gets medical device approval
Shandong Oriental Ocean Sci-Tech Co., Ltd. [SZSE:002086] announced that its wholly-owned subsidiary, Avik Biotechnology Co., Ltd., has received approval from the Shandong Provincial Drug Administration for its 25-Hydroxyvitamin D (25-OH VD) assay kit (magnetic particle chemiluminescence method). The registration is valid from March 26, 2025, to March 25, 2030. The kit is designed for the in-vitro quantitative determination of 25-Hydroxyvitamin D levels in human serum or plasma samples. While this expands Avik Biotech's clinical testing product line, the company cautions that the actual impact on future performance is uncertain due to market factors and that it has not yet started production of the product. Investors are advised to exercise caution.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shandong Oriental Ocean Sci-Tech publishes news
Free account required • Unsubscribe anytime